Strides Pharma Sets July 31, 2026 Record Date for FY26 Final Dividend

Strides Pharma Science Ltd has announced Friday, July 31, 2026, as the record date for determining shareholder entitlement to the final dividend for the financial year ended March 31, 2026. The company's Board of Directors had previously recommended a final dividend of ₹5 per equity share (50%). This dividend is subject to shareholder approval at the upcoming 35th Annual General Meeting (AGM), scheduled for Friday, August 14, 2026. The dividend, if approved, will be paid within 30 days of declaration, subject to applicable taxes.